Table 5.
Subgroup Bivariate Analysis Between ASA II and ASA III Patients for 30-Day Outcomes (N = 5488).a
| ASA Class II | ASA Class III | ||||
|---|---|---|---|---|---|
| Category | n | % | n | % | P Value |
| Mortality | 1 | 0.0% | 23 | 0.8% | <.0001 |
| Any complication | 635 | 24.8% | 1076 | 36.8% | <.0001 |
| LOS ≥5 days | 542 | 21.2% | 1013 | 34.6% | <.0001 |
| Wound complication | 40 | 1.6% | 94 | 3.2% | .0001 |
| Pulmonary complication | 37 | 1.4% | 99 | 3.4% | <.0001 |
| Venous thromboembolism | 43 | 1.7% | 53 | 1.8% | .7104 |
| Renal complication | 16 | 0.6% | 40 | 1.4% | .0064 |
| Urinary tract infection | 37 | 1.4% | 80 | 2.7% | .0010 |
| Peripheral nerve injury | 0 | 0.0% | 5 | 0.2% | .0364 |
| Cardiac complication | 6 | 0.2% | 26 | 0.9% | .0015 |
| Intra-/postoperative RBC transfusion | 557 | 21.7% | 928 | 31.7% | <.0001 |
| Sepsis | 23 | 0.9% | 69 | 2.4% | <.0001 |
| CNS complication | 5 | 0.2% | 6 | 0.2% | .9358 |
| Reoperation (related to initial procedure) | 69 | 2.9% | 134 | 4.9% | .0003 |
| Unplanned readmission (related to initial procedure) | 98 | 4.2% | 211 | 7.8% | <.0001 |
Abbreviations: ASA, American Society for Anesthesiologists; LOS, length of stay; RBC, red blood cell; CNS, central nervous system.
aBolded values indicate statistical significance.